Interferon-alpha-induced acute renal allograft rejection.
about
Interventions for dialysis patients with hepatitis C virus (HCV) infectionManaging chronic hepatitis C in the difficult-to-treat patientPegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.Type I interferons are not critical for skin allograft rejection or the generation of donor-specific CD8+ memory T cells.The effects of tolerance on allograft damage caused by the innate immune systemInterferon and cytotoxic chemotherapy for the treatment of post-transplant lymphoproliferative disorder.Incidence and severity of acute allograft rejection in liver transplant recipients treated with alfa interferonManagement of hepatitis C in patients with chronic kidney disease.Treatment of recurrent hepatitis C.Hepatitis C and kidney transplantationManagement of patients with hepatitis C infection and renal disease.Kidney transplantation from donors with hepatitis C infection.Mortality from infections and malignancies in patients treated with renal replacement therapy: data from the ERA-EDTA registry.Efficacy and safety of treatment of hepatitis C virus infection in renal transplant recipientsHepatitis B virus infection and renal transplantationTreatment of hepatitis C virus infection in patients with end-stage renal disease.Chronic viral hepatitis in kidney transplantation.Pharmacological management of Kaposi's sarcoma.Hepatitis E virus: an underdiagnosed cause of chronic hepatitis in renal transplant recipients.Treatment of hepatitis C after kidney transplant: a pooled analysis of observational studies.Hepatitis C virus infection in end-stage renal disease and kidney transplantation.Hepatitis B in renal transplant patients.Hepatitis B virus infection and liver transplantation.Hepatitis C eradication and improvement of cryoglobulinemia-associated rash and membranoproliferative glomerulonephritis with interferon and ribavirin after kidney transplantation.Post-transplant lymphoproliferative disorder following renal transplantation: a single-center experience over 40 years.Lamivudine treatment for hepatitis B reactivation in HBsAg carriers after organ transplantation: a 4-year experience.Direct-Acting Antiviral Agents for the Hepatitis C Virus-Infected Chronic Kidney Disease Population: The Dawn of a New Era.Liver-kidney recipients with chronic viral hepatitis C treated with interferon-alpha.Does the antiviral therapy of patients with chronic hepatitis exert nephrotoxic effects?Pegylated interferon-alpha-based treatment for chronic hepatitis C in renal transplant recipients: an open pilot study.Chronic hepatitis C
P2860
Q24187826-C4AB0974-E947-4370-962F-00D28F0F43CAQ27490409-2D43B236-D87C-4AB5-89BC-A44C3FF85417Q33371890-D1CFC2E7-8CD2-4285-86CB-4170D72D14CDQ33592472-EB68F6D1-C4AB-4A7D-9052-41D43AC10BAFQ33757956-AE835E0F-8ADF-4A18-88FA-35E11832AAE2Q34275888-59056C45-E96E-47D8-B369-C6C80C97A54BQ34423385-975017CB-CC27-40C2-A5BF-3BD8D91E70DEQ34932338-D5607B6B-B9F8-481C-828F-D8477DEA28F2Q34936164-05F04929-0C51-4462-8D31-09903A9EFAB5Q35094769-280DAF82-E690-4594-B908-C28D89AD169FQ35127041-F057B4E8-0A5E-4EF5-B637-5168F7B596E1Q35128555-3AC60FA7-993F-453C-AF66-096A710AE070Q35552358-97C343C1-DF6A-4932-89FA-73121116375FQ35653600-7023A2AB-E763-4198-A33B-EECFF05B8795Q37780176-D73EB6BB-7F97-403B-BD7F-04F90674C07DQ37831965-81F776ED-E58A-4922-AB15-64C2AFBF078EQ37833898-CFAD4365-4B0A-4A6E-A733-32891B8FE5D1Q37868566-D060E0FD-DB51-4BFA-B343-57CF75B247E3Q37957375-CF6EDB3C-0331-4C07-A631-BBE42F67C62BQ38194499-310A40B5-1592-453D-AE75-9268731F1483Q38213956-568117FF-FBA4-4DDC-879A-C9B47EC424F2Q41690591-B49105E6-4510-4DFA-A3FF-C5C23490AD7BQ42581069-231EA379-ED61-4BCB-BD21-31726B6AA981Q43157677-33C941C4-C71C-4B51-94AF-907F7D4F1539Q43225381-B2CAFC84-6F54-4766-BC90-D3C82BF24997Q43762367-828B1C2B-8A5C-4882-AA40-F21461C907E7Q43969652-7F785D29-BCCC-42EE-9356-9A0805A931AEQ45811492-ADDEB9AD-66B1-40BD-BBB0-58B7F55BC120Q50557265-A1D064EE-9FC9-4075-9679-A05CA839A1BFQ50565078-EE244C85-E449-4FDB-A3C6-0F8CF8919A9BQ56929229-11D6B45C-4508-42A5-A732-37F13EE5911B
P2860
Interferon-alpha-induced acute renal allograft rejection.
description
1995 nî lūn-bûn
@nan
1995 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Interferon-alpha-induced acute renal allograft rejection.
@ast
Interferon-alpha-induced acute renal allograft rejection.
@en
Interferon-alpha-induced acute renal allograft rejection.
@nl
type
label
Interferon-alpha-induced acute renal allograft rejection.
@ast
Interferon-alpha-induced acute renal allograft rejection.
@en
Interferon-alpha-induced acute renal allograft rejection.
@nl
prefLabel
Interferon-alpha-induced acute renal allograft rejection.
@ast
Interferon-alpha-induced acute renal allograft rejection.
@en
Interferon-alpha-induced acute renal allograft rejection.
@nl
P2093
P2860
P1433
P1476
Interferon-alpha-induced acute renal allograft rejection.
@en
P2093
J L Holley
J McCauley
J P Johnson
V Scantlebury
P2860
P304
P356
10.1097/00007890-199504150-00030
P577
1995-04-01T00:00:00Z